Research Paper Volume 15, Issue 11 pp 5125—5143
Network pharmacology-based research on the effect of angelicin on osteosarcoma and the underlying mechanism
Figure 11. Wound healing experiment. Angelicin inhibits the migration of osteosarcoma MG63 cells. MG63 osteosarcoma cell wound healing results at different time points (0 h, 24 h, or 48 h) of culture with media containing different angelicin concentrations (0 μmol/ml, 50 μmol, or 200 μmol/ml). The results of quantitative analysis are shown as the mean ± S.D. of three independent experiments. *Significant difference between the two groups: p < 0.05, ****p < 0.0001.